Literature DB >> 22178886

Chloride-led disruption of the intestinal mucous layer impedes Salmonella invasion: evidence for an 'enteric tear' mechanism.

Simon Keely1, Linda Feighery, Deirdre P Campion, Leah O'Brien, David J Brayden, Alan W Baird.   

Abstract

METHODS: The intestinal epithelial layer can switch from a net absorptive state to one of net secretion in the presence of luminal toxins and pathogens. This suggests an innate defence role for regulated secretion of mucus, electrolytes and water. We hypothesised that chloride-led fluid secretion across the mucus-covered intestinal epithelium alters barrier properties by influencing the overlying mucous-gel layer.
RESULTS: We demonstrated that chloride-led disruption of the epithelial-associated mucus-gel covering HT29-MTX-E12 (E12) human colonic epithelial monolayers, a goblet-cell like line derived from parental HT29 cells, resulted in reduction of associated mucus as well as a reduction in mucous-gel density and barrier properties. Changes in epithelial secretory state were accompanied by increased water transport, and the resulting loss of gel integrity reduced Salmonella typhimurium invasion of epithelia in both E12 monolayers and of isolated rat ileal mucosae. However, neither chloride secretion nor mucus disruption altered numbers of adhering bacteria.
CONCLUSION: These data suggest a role for chloride led fluid secretion in the shedding of the adherent mucous-gel layer, possibly as a rate-limiting innate defence mechanism, and offer evidence for "enteric tears" in intestinal host defence.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22178886     DOI: 10.1159/000335768

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  8 in total

Review 1.  Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

2.  Ex Vivo Intestinal Sacs to Assess Mucosal Permeability in Models of Gastrointestinal Disease.

Authors:  Sean W Mateer; Jocelle Cardona; Ellen Marks; Bridie J Goggin; Susan Hua; Simon Keely
Journal:  J Vis Exp       Date:  2016-02-09       Impact factor: 1.355

3.  MarvelD3 Is Upregulated in Ulcerative Colitis and Has Attenuating Effects during Colitis Indirectly Stabilizing the Intestinal Barrier.

Authors:  Franziska Weiß; Carolina Czichos; Lukas Knobe; Lena Voges; Christian Bojarski; Geert Michel; Michael Fromm; Susanne M Krug
Journal:  Cells       Date:  2022-05-04       Impact factor: 7.666

4.  Tricellulin is regulated via interleukin-13-receptor α2, affects macromolecule uptake, and is decreased in ulcerative colitis.

Authors:  S M Krug; C Bojarski; A Fromm; I M Lee; P Dames; J F Richter; J R Turner; M Fromm; J-D Schulzke
Journal:  Mucosal Immunol       Date:  2017-06-14       Impact factor: 7.313

Review 5.  Significance of Ligand-Anchored Polymers for Drug Targeting in the Treatment of Colonic Disorders.

Authors:  Pramila Chaubey; Munira Momin; Sujata Sawarkar
Journal:  Front Pharmacol       Date:  2020-02-25       Impact factor: 5.810

Review 6.  Development and Functional Properties of Intestinal Mucus Layer in Poultry.

Authors:  Yada Duangnumsawang; Jürgen Zentek; Farshad Goodarzi Boroojeni
Journal:  Front Immunol       Date:  2021-10-04       Impact factor: 7.561

7.  Contribution of epithelial innate immunity to systemic protection afforded by prolyl hydroxylase inhibition in murine colitis.

Authors:  S Keely; E L Campbell; A W Baird; P M Hansbro; R A Shalwitz; A Kotsakis; E N McNamee; H K Eltzschig; D J Kominsky; S P Colgan
Journal:  Mucosal Immunol       Date:  2013-05-22       Impact factor: 7.313

8.  Soluble Non-Starch Polysaccharides From Plantain (Musa x paradisiaca L.) Diminish Epithelial Impact of Clostridioides difficile.

Authors:  Hannah L Simpson; Carol L Roberts; Louise M Thompson; Cameron R Leiper; Nehana Gittens; Ellie Trotter; Carrie A Duckworth; Stamatia Papoutsopoulou; Fabio Miyajima; Paul Roberts; Niamh O'Kennedy; Jonathan M Rhodes; Barry J Campbell
Journal:  Front Pharmacol       Date:  2021-12-10       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.